Australian first: Little Green Pharma (ASX: LGP) sends medicinal cannabis oils to Germany, page-5

I think LGP is great but to say its profitable is misleading. It does have a lot of great things going for it though:
- increasing domestic sales showing good product potential
- product costs to consumers coming down with health fund support
- vertically integrated in what has to be one of the highest margin industries
- 110k bottle a year eq production capability, $250 a bottle
- most set up costs behind them
- clear leader amongst Australian CBD oil companies although to be fair the others aren't doing much except capital raises
- management actually have a plan so if capital raisings do happen shareholders wont be annoyed
- management has skin in the game, stayed in EU setting up the next export market during covid. Working hard for our investment.
- looks like they have a chance at the next quarter being positive operating cash flow

Now its about sales. If they can get the inventory turning over and get a decent market penetration overseas while the margins are still insane they will have the cash and customer base to cusion the blow and pivot when the industry matures and the margins fall. Its about setting up now to survive for the long haul where LGP wont be so little anymore.